Some of the industry’s biggest players say the FDA’s deadline to switch to natural colors may not be feasible due to supply constraints and other challenges.

Some of the industry’s biggest players say the FDA’s deadline to switch to natural colors may not be feasible due to supply constraints and other challenges.